These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 3079064

  • 1. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E, Bachetoni A, Cinti P, Sallustio F, Rossi M, Pretagostini R, Orlandini A, Berloco P, Alfani D, Cortesini R.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract] [Full Text] [Related]

  • 2. Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patients.
    Cortesini R, Berloco P, Famulari A, Trovati A, Iappelli M, Renna Molajoni E, Bachetoni A, Pretagostini R, Marinucci G, Capua A.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1949-50. PubMed ID: 3079063
    [No Abstract] [Full Text] [Related]

  • 3. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M, Schleibner S, Abendroth D, Illner WD, Schneeberger H, Land W.
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 6. Conversion to triple therapy in renal allograft patients with renal dysfunction and chronic interstitial lesions or vascular lesions on renal biopsy.
    Leaker B, Neild GH, Rudge C, Mansell M, Thompson FD.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1548-9. PubMed ID: 2652501
    [No Abstract] [Full Text] [Related]

  • 7. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD, Hopt UT, Müller GH, Greger B, Risler T, Bockhorn H.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract] [Full Text] [Related]

  • 8. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y, Ohshima S, Fujita T, Kinukawa T, Matsuura O, Hirabayashi S, Takeuchi N.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract] [Full Text] [Related]

  • 9. Adrenal function as an index of the immunosuppressive activity of glucocorticoids (prednisolone) in renal allograft recipients.
    Kozaki M, Hirano T, Oka K.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2237-9. PubMed ID: 3079076
    [No Abstract] [Full Text] [Related]

  • 10. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H, May G, Müller P, Strobelt V, Seeger W, Seibt F, Horlbeck R, Hansen C.
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Single center randomized trial using ATG v OKT3 treatment in steroid resistant rejection crises after kidney transplantation.
    Blümke M, Kirste G, Wanner U, Wilms H.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1747. PubMed ID: 2652571
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunosuppression with cyclosporine, azathioprine, and prednisolone in cadaver renal allograft recipients.
    Jones RM, Murie JA, Allen R, Jaskowski A, Morris PJ.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1926. PubMed ID: 3274453
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC, Sibley RK, Fryd DS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract] [Full Text] [Related]

  • 17. Discontinuation of one drug in triple drug treatment of renal allograft patients: 1-year results.
    Isoniemi H, Eklund B, Höckerstedt K, Korsbäck C, Salmela K, von Willebrand E, Häyry P, Ahonen J.
    Transplant Proc; 1990 Aug; 22(4):1365-6. PubMed ID: 2202111
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
    Büsing M, Hölzer H, Schareck WD, Mellert J, Greger B, Hopt UT, Lauchart W.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1601-3. PubMed ID: 2652521
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.